Cochlear | COH - Operating Profit

Stock Price
172.43
Daily Change
-1.27 -0.73%
Monthly
-13.76%
Yearly
-36.01%
Q1 Forecast
170.76

Cochlear reported AUD261.1M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Ansell USD 146.5M 87.85M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Healius AUD -22.6M 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Mesoblast USD -42.11M 21.69M Jun/2025
Monash IVF AUD 18M 10.11M Dec/2025
Nanosonics AUD 9.12M 3.82M Dec/2025
Polynovo AUD 513K 902K Jun/2024
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
Regis Healthcare AUD 24.67M 11.91M Dec/2025
ResMed USD 500.3M 37.95M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Somnomed AUD -4.16M 1.28M Jun/2023
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025